Prevention of bisphosphonate-related osteonecrosis of the jaw (BRONJ): evaluation of the effectiveness of different substances in rats

Detalhes bibliográficos
Autor(a) principal: Weiss, Suyany Gabriely
Data de Publicação: 2020
Tipo de documento: Tese
Idioma: por
Título da fonte: Repositório do Centro Universitário Braz Cubas
Texto Completo: https://repositorio.cruzeirodosul.edu.br/handle/123456789/2177
Resumo: Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is a serious complication associated with dental intervention and the long-term use of bisphosphonates, a class of drugs used to treat bone pathologies, such as osteoporosis and bone metastases. The purpose of this study is to evaluate the effectiveness of substances in preventing BRONJ. Thirty-six (n = 36) Wistar rats were used, females (n = 18) and males (n = 18). All rats received a weekly intravenous injection of 0.3 mL via a caudal vein of zoledronate (80 μg / kg body weight in PBS) for 8 weeks. Then, the animals underwent surgery to remove the first and second right and left mandibular molars to induce osteonecrosis. Males and females were equally distributed according to the substance in two large groups: biochelating biomaterial (n = 12), in a split-mouth study, and association of pentoxifylline and tocopherol (PENTO) (n = 12) in a case-control study. The bio-chelating group received a local application of 17% EDTA on the right side after extractions at the time of surgery while the left side received irrigation with saline solution. Twelve animals in the PENTO group received a combined suspension of the two substances (5.71 mg pentoxifylline and 7.14 IU tocopherol) via gavage once daily for 6 weeks. Twelve animals were allocated to a control group for the PENTO that received weekly intraperitoneal saline applications, once a week for 6 weeks. Clinical assessments were made by assessing the presence of the following characteristics: bone exposure, inflammation, suppuration, bone sequestration and epithelialization. In addition, the mesio-distal distances as well as the buccal-lingual bone exposure were obtained for each animal. The data were submitted to statistical analysis with a significance level of 0.05. It was possible to observe that in the bio-chelating biomaterial group there was no statistically significant difference in relation to the clinical data for bone exposure, bone sequestration, suppuration, inflammation and epithelialization (p> 0.05). Regarding the size of bone exposure, there was no statistically significant difference between the right and left sides (p = 0.197). The PENTO group demonstrated a lower incidence of bone sequestration when compared to the control (p = 0.006), no other statistically significant difference was obtained in relation to the others observed clinical data (p> 0.05). The PENTO group showed even less bone exposure on the buccal-lingual aspect (p = 0.041) when compared to the control. It is concluded that the PENTO group had more favorable clinical results related to BRONJ when compared to the control.
id CUB_25cdb584b98addaa8dbb7ec072730f5b
oai_identifier_str oai:repositorio.cruzeirodosul.edu.br:123456789/2177
network_acronym_str CUB
network_name_str Repositório do Centro Universitário Braz Cubas
repository_id_str
spelling Prevention of bisphosphonate-related osteonecrosis of the jaw (BRONJ): evaluation of the effectiveness of different substances in ratsOdontologiaOsteonecroseDifosfonatosPentoxifilinaTocoferóisCNPQ::CIENCIAS DA SAUDE::ODONTOLOGIABisphosphonate-related osteonecrosis of the jaws (BRONJ) is a serious complication associated with dental intervention and the long-term use of bisphosphonates, a class of drugs used to treat bone pathologies, such as osteoporosis and bone metastases. The purpose of this study is to evaluate the effectiveness of substances in preventing BRONJ. Thirty-six (n = 36) Wistar rats were used, females (n = 18) and males (n = 18). All rats received a weekly intravenous injection of 0.3 mL via a caudal vein of zoledronate (80 μg / kg body weight in PBS) for 8 weeks. Then, the animals underwent surgery to remove the first and second right and left mandibular molars to induce osteonecrosis. Males and females were equally distributed according to the substance in two large groups: biochelating biomaterial (n = 12), in a split-mouth study, and association of pentoxifylline and tocopherol (PENTO) (n = 12) in a case-control study. The bio-chelating group received a local application of 17% EDTA on the right side after extractions at the time of surgery while the left side received irrigation with saline solution. Twelve animals in the PENTO group received a combined suspension of the two substances (5.71 mg pentoxifylline and 7.14 IU tocopherol) via gavage once daily for 6 weeks. Twelve animals were allocated to a control group for the PENTO that received weekly intraperitoneal saline applications, once a week for 6 weeks. Clinical assessments were made by assessing the presence of the following characteristics: bone exposure, inflammation, suppuration, bone sequestration and epithelialization. In addition, the mesio-distal distances as well as the buccal-lingual bone exposure were obtained for each animal. The data were submitted to statistical analysis with a significance level of 0.05. It was possible to observe that in the bio-chelating biomaterial group there was no statistically significant difference in relation to the clinical data for bone exposure, bone sequestration, suppuration, inflammation and epithelialization (p> 0.05). Regarding the size of bone exposure, there was no statistically significant difference between the right and left sides (p = 0.197). The PENTO group demonstrated a lower incidence of bone sequestration when compared to the control (p = 0.006), no other statistically significant difference was obtained in relation to the others observed clinical data (p> 0.05). The PENTO group showed even less bone exposure on the buccal-lingual aspect (p = 0.041) when compared to the control. It is concluded that the PENTO group had more favorable clinical results related to BRONJ when compared to the control.A osteonecrose dos maxilares relacionada aos bisfosfonatos (BRONJ) é uma complicação grave associada à intervenção odontológica e ao uso a longo prazo de bifosfonatos, uma classe de medicamentos utilizados para o tratamento de patologias ósseas, tais como osteoporose e metástases ósseas. O objetivo deste estudo é avaliar a efetividade de substâncias na prevenção da BRONJ após exodontia. Trinta e seis (n = 36) ratos Wistar foram utilizados, fêmeas (n = 18) e machos (n = 18). Para a indução da osteonecrose, todos os ratos receberam uma injeção intravenosa semanal de 0,3 mL via veia caudal de zoledronato (80 μg/kg de peso corporal em PBS) por 8 semanas. Em seguida, os animais foram submetidos à cirurgia para remoção dos primeiros molares inferiores direito e esquerdo, e na semana seguinte remoção dos segundos molares inferiores direito e esquerdo. Os machos e fêmeas foram igualmente distribuídos de acordo com a substância em dois grandes grupos: biomaterial bioquelante (n = 12), em um estudo de boca dividida e associação de pentoxifilina e tocoferol (PENTO) (n = 12) em um estudo de casocontrole. O grupo bioquelante recebeu aplicação local de EDTA a 17% no lado direito após as exodontias no momento da cirurgia enquanto o lado esquerdo recebeu irrigação com solução salina. Doze animais do grupo PENTO receberam uma suspensão combinada das duas substâncias (5,71 mg pentoxifilina e 7,14 UI de tocoferol) via gavagem uma vez ao dia por 6 semanas. Doze animais foram alocados em um grupo controle para o PENTO que recebeu aplicações semanais intraperitoneais de solução fisiológica, uma vez na semana por 6 semanas. As avaliações clínicas foram feitas através da avaliação da presença das seguintes características: exposição óssea, inflamação, supuração, sequestro ósseo e epitelização. Além disso, as distâncias mésio-distal bem como vestíbulo-lingual da exposição óssea foram obtidas para cada animal. Os dados foram submetidos a análise estatística com nível de significância de 0,05. Foi possível observar que no grupo bioquelante não houve diferença estatisticamente significante em relação aos dados clínicos para exposição óssea, sequestro ósseo, supuração, inflamação e epitelização (p > 0,05). Em relação ao tamanho da exposição óssea, não houve diferença estatisticamente significativa entre os lados direito e esquerdo (p = 0,197). O grupo PENTO demonstrou menor incidência de sequestro ósseo quando comparado ao controle (p = 0,006), nenhuma outra diferença estatisticamente significante foi obtida em relação aos outros dados clínicos observados (p > 0,05). O grupo PENTO apresentou ainda menor exposição óssea na face vestíbulolingual (p = 0,041) quando comparado ao controle. Conclui-se que o grupo PENTO apresentou resultados clinicamente mais favoráveis relacionadas a BRONJ quando comparado ao controle.Universidade PositivoBrasilPós-GraduaçãoPrograma de Pós-Graduação em Odontologia ClínicaUPDeliberador, Tatiana Mirandahttp://lattes.cnpq.br/4688659299176448Elsalanty, MohammedScariot, Rafaelahttp://lattes.cnpq.br/8726711027143249Weiss, Suyany Gabriely2021-05-14T20:23:55Z20202021-05-14T20:23:55Z2020info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisapplication/pdfhttps://repositorio.cruzeirodosul.edu.br/handle/123456789/2177porinfo:eu-repo/semantics/openAccessreponame:Repositório do Centro Universitário Braz Cubasinstname:Centro Universitário Braz Cubas (CUB)instacron:CUB2021-06-24T12:19:35Zoai:repositorio.cruzeirodosul.edu.br:123456789/2177Repositório InstitucionalPUBhttps://repositorio.brazcubas.edu.br/oai/requestbibli@brazcubas.edu.bropendoar:2021-06-24T12:19:35Repositório do Centro Universitário Braz Cubas - Centro Universitário Braz Cubas (CUB)false
dc.title.none.fl_str_mv Prevention of bisphosphonate-related osteonecrosis of the jaw (BRONJ): evaluation of the effectiveness of different substances in rats
title Prevention of bisphosphonate-related osteonecrosis of the jaw (BRONJ): evaluation of the effectiveness of different substances in rats
spellingShingle Prevention of bisphosphonate-related osteonecrosis of the jaw (BRONJ): evaluation of the effectiveness of different substances in rats
Weiss, Suyany Gabriely
Odontologia
Osteonecrose
Difosfonatos
Pentoxifilina
Tocoferóis
CNPQ::CIENCIAS DA SAUDE::ODONTOLOGIA
title_short Prevention of bisphosphonate-related osteonecrosis of the jaw (BRONJ): evaluation of the effectiveness of different substances in rats
title_full Prevention of bisphosphonate-related osteonecrosis of the jaw (BRONJ): evaluation of the effectiveness of different substances in rats
title_fullStr Prevention of bisphosphonate-related osteonecrosis of the jaw (BRONJ): evaluation of the effectiveness of different substances in rats
title_full_unstemmed Prevention of bisphosphonate-related osteonecrosis of the jaw (BRONJ): evaluation of the effectiveness of different substances in rats
title_sort Prevention of bisphosphonate-related osteonecrosis of the jaw (BRONJ): evaluation of the effectiveness of different substances in rats
author Weiss, Suyany Gabriely
author_facet Weiss, Suyany Gabriely
author_role author
dc.contributor.none.fl_str_mv Deliberador, Tatiana Miranda
http://lattes.cnpq.br/4688659299176448
Elsalanty, Mohammed
Scariot, Rafaela
http://lattes.cnpq.br/8726711027143249
dc.contributor.author.fl_str_mv Weiss, Suyany Gabriely
dc.subject.por.fl_str_mv Odontologia
Osteonecrose
Difosfonatos
Pentoxifilina
Tocoferóis
CNPQ::CIENCIAS DA SAUDE::ODONTOLOGIA
topic Odontologia
Osteonecrose
Difosfonatos
Pentoxifilina
Tocoferóis
CNPQ::CIENCIAS DA SAUDE::ODONTOLOGIA
description Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is a serious complication associated with dental intervention and the long-term use of bisphosphonates, a class of drugs used to treat bone pathologies, such as osteoporosis and bone metastases. The purpose of this study is to evaluate the effectiveness of substances in preventing BRONJ. Thirty-six (n = 36) Wistar rats were used, females (n = 18) and males (n = 18). All rats received a weekly intravenous injection of 0.3 mL via a caudal vein of zoledronate (80 μg / kg body weight in PBS) for 8 weeks. Then, the animals underwent surgery to remove the first and second right and left mandibular molars to induce osteonecrosis. Males and females were equally distributed according to the substance in two large groups: biochelating biomaterial (n = 12), in a split-mouth study, and association of pentoxifylline and tocopherol (PENTO) (n = 12) in a case-control study. The bio-chelating group received a local application of 17% EDTA on the right side after extractions at the time of surgery while the left side received irrigation with saline solution. Twelve animals in the PENTO group received a combined suspension of the two substances (5.71 mg pentoxifylline and 7.14 IU tocopherol) via gavage once daily for 6 weeks. Twelve animals were allocated to a control group for the PENTO that received weekly intraperitoneal saline applications, once a week for 6 weeks. Clinical assessments were made by assessing the presence of the following characteristics: bone exposure, inflammation, suppuration, bone sequestration and epithelialization. In addition, the mesio-distal distances as well as the buccal-lingual bone exposure were obtained for each animal. The data were submitted to statistical analysis with a significance level of 0.05. It was possible to observe that in the bio-chelating biomaterial group there was no statistically significant difference in relation to the clinical data for bone exposure, bone sequestration, suppuration, inflammation and epithelialization (p> 0.05). Regarding the size of bone exposure, there was no statistically significant difference between the right and left sides (p = 0.197). The PENTO group demonstrated a lower incidence of bone sequestration when compared to the control (p = 0.006), no other statistically significant difference was obtained in relation to the others observed clinical data (p> 0.05). The PENTO group showed even less bone exposure on the buccal-lingual aspect (p = 0.041) when compared to the control. It is concluded that the PENTO group had more favorable clinical results related to BRONJ when compared to the control.
publishDate 2020
dc.date.none.fl_str_mv 2020
2020
2021-05-14T20:23:55Z
2021-05-14T20:23:55Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://repositorio.cruzeirodosul.edu.br/handle/123456789/2177
url https://repositorio.cruzeirodosul.edu.br/handle/123456789/2177
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Positivo
Brasil
Pós-Graduação
Programa de Pós-Graduação em Odontologia Clínica
UP
publisher.none.fl_str_mv Universidade Positivo
Brasil
Pós-Graduação
Programa de Pós-Graduação em Odontologia Clínica
UP
dc.source.none.fl_str_mv reponame:Repositório do Centro Universitário Braz Cubas
instname:Centro Universitário Braz Cubas (CUB)
instacron:CUB
instname_str Centro Universitário Braz Cubas (CUB)
instacron_str CUB
institution CUB
reponame_str Repositório do Centro Universitário Braz Cubas
collection Repositório do Centro Universitário Braz Cubas
repository.name.fl_str_mv Repositório do Centro Universitário Braz Cubas - Centro Universitário Braz Cubas (CUB)
repository.mail.fl_str_mv bibli@brazcubas.edu.br
_version_ 1798311353749864448